SLNO NASDAQ
Soleno Therapeutics, Inc.
1W: +0.1%
1M: +0.8%
3M: +42.4%
YTD: +12.4%
1Y: -27.8%
3Y: +161.8%
5Y: -34.6%
$53.01
Last traded 2026-05-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.8B
52W Range29.43-90.3199
Volume4,968,834
Avg Volume3,449,573
Beta-2.22
Dividend—
Analyst Ratings
Company Info
CEOAnish Bhatnagar
Employees115
SectorHealthcare
IndustryBiotechnology
IPO Date2014-11-13
Websitesoleno.life
203 Redwood Shores Parkway
Redwood City, CA 94065
US
Redwood City, CA 94065
US
650 213 8444
About Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Latest News
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO
Halper Sadeh LLC is Investigating Whether SLNO, OGN, RMAX, XOMA are Obtaining Fair Deals for their Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
Halper Sadeh LLC is Investigating Whether SLNO, APLS, HLX are Obtaining Fair Deals for their Shareholders
DEADLINE ALERT for EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Yen Kristen | D-Return | 37,639 | — | 2026-05-18 |
| Yen Kristen | D-Return | 1,741 | $44.25 | 2026-05-18 |
| Yen Kristen | D-Return | 4,999 | $24.00 | 2026-05-18 |
| Yen Kristen | D-Return | 4,000 | $25.05 | 2026-05-18 |
| Yen Kristen | D-Return | 666 | $51.15 | 2026-05-18 |